We are live on ! Find out more
AH

Aviva Holdings Portfolio holdings

AUM $20.5M
1-Year Est. Return 117.01%
This Fund
S&P 500
This Quarter Est. Return
+49.54%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$456M
AUM Growth
+$139M
Cap. Flow
-$13.2M
Cap. Flow %
-2.89%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$1.03M
2
MGNX icon
MacroGenics
MGNX
+$48K

Sector Composition

Rank Sector Weight
1 Healthcare 77.51%
2 Technology 19.47%
3 Miscellaneous 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$230M 50.43%
3,135,966
– –
MDCO
2
DELISTED
Medicines Co
MDCO
$106M 23.17%
3,778,742
– –
INSG icon
3
Inseego
INSG
$72.7M
$88.7M 19.47%
1,879,923
– –
ESPR
4
DELISTED
Esperion Therapeutics
ESPR
$17.7M 3.89%
441,649
-23,000
-5% -$1.03M
SLDB icon
5
Solid Biosciences
SLDB
$1.09B
$106K 0.02%
766
– –
MGNX icon
6
MacroGenics
MGNX
$263M
– –
-3,815
Closed -$48K

Similar funds

MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return

Aviva Holdings's Q1 2019 Portfolio in Review

As of Q1 2019, Aviva Holdings held 7 positions worth $456M, up 44% from $317M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aviva Holdings's Q1 2019 filing shows 1 reduced and 1 closed positions. The largest sale was Esperion Therapeutics, an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 72% a quarter earlier, followed by Technology and Miscellaneous.

  • Aviva Holdings's biggest Q1 2019 reduction was Esperion Therapeutics, cutting an estimated $1.03M.
  • Aviva Holdings fully exited MacroGenics in Q1 2019, selling an estimated $48K.
  • Aviva Holdings's ten largest holdings make up 100% of its $456M portfolio in Q1 2019.
  • Aviva Holdings opened 0 new positions and closed 1 in Q1 2019.
  • Aviva Holdings's portfolio value rose 44% quarter-over-quarter to $456M.

Based on Aviva Holdings's 13F filing for Q1 2019, filed 15 May 2019.